SCHEMBL29834853

SCHEMBL29834853

CNC(=O)c1cc(Oc2ccc(NC(=O)c3cc(-c4cccc(C)c4)ccn3)cc2)ccn1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 9/20 0.62
MAPK14 Q16539 5/20 0.59
HIPK4 Q8NE63 4/20 0.59
RET P07949 3/20 0.59
PLK4 O00444 2/20 0.59
AURKA O14965 2/20 0.59
MAPK13 O15264 2/20 0.59
MAP4K4 O95819 2/20 0.59
ABL1 P00519 2/20 0.59
LCK P06239 2/20 0.59
FYN P06241 2/20 0.59
LYN P07948 2/20 0.59
SRC P12931 2/20 0.59
RPS6KB1 P23443 2/20 0.59
EPHA2 P29317 2/20 0.59
AXL P30530 2/20 0.59
FRK P42685 2/20 0.59
MAPK9 P45984 2/20 0.59
BLK P51451 2/20 0.59
CAMK2B Q13554 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26922379 1.00 KDR (0.62) KDRMAPK14HIPK4RETPLK4
SCHEMBL29834835 0.93 KDR (0.57) KDRMAPK14HIPK4RETPLK4
SCHEMBL26922708 0.93 KDR (0.57) KDRMAPK14HIPK4RETPLK4
SCHEMBL29834896 0.90 KDR (0.62) KDRMAPK14HIPK4RETPLK4
SCHEMBL27173866 0.90 KDR (0.62) KDRMAPK14HIPK4RETPLK4
SCHEMBL29834825 0.89 KDR (0.63) KDRMAPK14HIPK4RETPLK4
SCHEMBL26922701 0.89 KDR (0.63) KDRMAPK14HIPK4RETPLK4
SCHEMBL29834816 0.88 KDR (0.63) KDRMAPK14HIPK4RETPLK4
SCHEMBL26922854 0.88 KDR (0.63) KDRMAPK14HIPK4RETPLK4
SCHEMBL29834823 0.85 KDR (0.57) KDRMAPK14HIPK4RETPLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4288539-A1 COMPOSITIONS AND METHODS FOR TREATING DISEASE ASSOCIATED WITH DUX4 OVEREXPRESSION Research Institute at Nationwide Children's Hospital (US) 2023-12-13 EP disclosed
WO-2022169922-A1 COMPOSITIONS AND METHODS FOR TREATING DISEASE ASSOCIATED WITH DUX4 OVEREXPRESSION RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL (US) 2022-08-11 WO disclosed